PDMR Shareholding

Summary by AI ^BETAClose X

Eagle Eye Solutions Group PLC announced that its non-executive Chair, Anne de Kerckhove, purchased 3,921 ordinary shares at £3.825 per share on April 24, 2026. This transaction increases her beneficial interest to 3,921 ordinary shares, representing 0.01% of the company's issued ordinary share capital.

Disclaimer*

Eagle Eye Solutions Group PLC

24 April 2026

Eagle Eye Solutions Group PLC

("Eagle Eye" or the "Company")

PDMR Shareholding

Eagle Eye, a leading provider of applied AI for marketing, enabling personalised, real-time engagement at scale, announces that it has been informed today that Anne de Kerckhove, non-executive Chair of Eagle Eye, has purchased 3,921 Ordinary Shares in the Company.

Following this transaction the beneficial interest of Anne de Kerckhove is 3,921 Ordinary Shares representing 0.01% of the issued Ordinary Share capital of the Company.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Anne de Kerckhove
2	Reason for the notification
a)	Position/status	Chair
b)	Initial notification/Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Eagle Eye Solutions Group plc
b)	LEI	2138002S1AIBVVMZ7A21
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1p each GB00BKF1YD83
b)	Nature of transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£3.825	3,921
	Aggregated information - Aggregated volume - Price	n/a
e)	Date of the transaction	24 April 2026
f)	Place of the transaction	AIM, London Stock Exchange

Enquiries:

Eagle Eye Solutions Group plc	Tel: 0844 824 3686
Tim Mason, Chief Executive Officer
Lucy Sharman-Munday, Chief Financial Officer


Canaccord Genuity Limited (Nominated Adviser and Joint Broker)	Tel: +44 20 7523 8000
Simon Bridges, Harry Gooden, Andrew Potts, Elizabeth Halley-Stott

Shore Capital (Joint Broker)	Tel: +44 20 7408 4090
Corporate Advisory: Daniel Bush, David Coaten, Lucy Bowden
Corporate Broking: Henry Willcocks


Alma Strategic Communications	Tel: +44 20 3405 0205
Caroline Forde, Hannah Campbell, Kinvara Verdon

About Eagle Eye

Eagle Eye is a leading provider of applied AI for marketing, enabling personalised, real-time engagement at scale for retail, travel and hospitality brands globally. Our powerful technology combines the world's most flexible and scalable loyalty and promotions capability with cutting edge, built-for-purpose AI to deliver 1:1 personalisation at scale for enterprise businesses, globally.

Our growing customer base includes Loblaws, Southeastern Grocers, Giant Eagle, Asda, Tesco, Morrisons, JD Sports, E.Leclerc, Carrefour, the Woolworths Group and many more. Each week, more than 1 billion personalised offers are seamlessly executed via our platform, and over 700 million loyalty member wallets are managed worldwide.

AI-powered, API-based and cloud-native, Eagle Eye's enterprise-grade technology is fully certified by the MACH Alliance and has received recognition from leading industry bodies, including Gartner, Forrester, IDC and QKS.

Web - www.eagleeye.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END